About Golden Helix

Enhancing Long-Read Alignment Visualization in GenomeBrowse

Jun 3, 2025

Long-read sequencing technologies have opened new doors in genomics research, enabling more comprehensive analysis of structural variants, phasing, and complex genomic regions. To support these powerful applications, we’ve introduced several new features to GenomeBrowse that specifically enhance the visualization of long-read alignment files. These improvements are designed to help our…

Read more →

Importing External PGx Calls for Extended Gene-Drug Reporting in VarSeq

May 27, 2025

Pharmacogenomic (PGx) analysis empowers researchers and clinicians to tailor drug therapies based on a patient’s genetic profile, but not all regions of the genome are easy to interpret. Genes like CYP2D6 and HLA-A are tricky when it comes to rendering diplotype calls. This is due to a number of factors…

Read more →

Golden Helix Launches Enterprise Genomic Analysis with VarSeq 3 and VSWarehouse 3

May 22, 2025

Today, we announced the release of VarSeq 3 and VSWarehouse 3, marking a major milestone in enterprise-scale secondary and tertiary genomic analysis. The release introduces cloud-native deployment options optimized for AWS and Azure, expanded support for hybrid and on-premise support, flexible licensing models, including per-sample packaging tailored to small and…

Read more →

Customized Auto Variant Interpretation in VarSeq

May 15, 2025

The VarSeq platform has been on the market for over a decade and has established itself as robust and powerful clinical-grade bioinformatics software. Its usage spans many types of analysis, including pharmacogenomics, rare disease, hereditary cancer, somatic, carrier risk, and trio/family. Fundamentally, users have the freedom to build any workflow…

Read more →

Leveraging ClinVar Curated Databases in VarSeq

May 13, 2025

ClinVar is a global, publicly accessible database maintained by the National Center for Biotechnology Information (NCBI) that archives interpretations of human genetic variants and their clinical relevance. ClinVar consists of contributions from clinical labs, expert panels, and research groups, and serves as a community-powered knowledge base that is foundational for…

Read more →

Automating Carrier Screening Analysis Using VarSeq

May 8, 2025

VarSeq, when used with VSPipeline, automates carrier screening analysis, allowing labs to run them in a parallelized, economical fashion.

Read more →

You Might Not Need Citrix

May 8, 2025

Your Genomic Analysis Platform Already Solves Remote Application Delivery Delivering enterprise applications to users is a solved problem, and for many organizations, that solution has been Citrix. It’s the de facto choice for centralizing and securing remote application access, especially for Windows environments. With the right IT support, it gets…

Read more →

Golden Helix Customer Publications

Apr 29, 2025

NGS Software is Bridging the Gap Between Discovery and Practical Application Researchers, clinicians, and scientists need cutting-edge solutions to better understand the complexities of human genetics. By delivering high-quality analysis tools and advancing the interpretation of genomic data, Golden Helix bridges the gap between discovery and practical application. Our NGS…

Read more →

Webcast Follow-Up: Powering Genomic Workflows with Upgraded Catalogs in VSWarehouse and VarSeq 3

Apr 24, 2025

Thank you to everyone who joined our recent webcast, “Powering Genomic Workflows with Upgraded Catalogs in VSWarehouse and VarSeq 3,” presented by Gabe Rudy on April 23rd, 2025. We appreciate the engagement and interest in the latest advancements to our platform. For those who missed it or need a recap,…

Read more →

Golden Helix Partners with the Danish Healthcare Regions to Drive Advancements in Genomic Medicine

Mar 10, 2025

Golden Helix, a global leader in bioinformatics solutions for Next-Generation Sequencing (NGS) and precision medicine, is proud to announce a multi-year agreement with all Danish healthcare regions. The agreement aims to enhance the genomic capabilities of multiple laboratories within the regions, supporting critical advancements in cancer and hereditary disease diagnostics.…

Read more →

Webcast Recap: Introducing VarSeq Dx as a Medical Device in the European Union

May 23, 2024

This last Wednesday we introduced VarSeq Dx Mode which enables customers to use VarSeq as a CE marked in vitro diagnostic medical device! If you missed our live webcast, no problem! You can watch the recording here. In brief, we started out discussing IVDR and that it establishes standardization for…

Read more →

Golden Helix Received ISO 13485:2016 Certification

Feb 6, 2024

This month, we are excited to announce that we have received the certification for ISO 13485:2016 from TÜV SÜD. ISO 13485:2016 is an international standard that specifies requirements for a quality management system (QMS) for organizations involved in the design, development, production, and servicing of medical devices. It is specifically…

Read more →

What to Expect from Golden Helix in 2024

Jan 10, 2024

Happy New Year! I hope that you all were able to enjoy quality time with loved ones over the holidays. 2023 has come to a close, and we would like to take the time to thank you while looking back on a year full of accomplishments. In 2023, we celebrated…

Read more →

Introducing VarSeq 2.5.0: Elevating NGS Labs to New Heights

Nov 9, 2023

We’re buzzing with excitement and couldn’t wait to share some groundbreaking news with our community: VarSeq 2.5.0 has officially landed, and it’s here to transform your NGS lab experience! What’s New with VarSeq 2.5.0? VarSeq has always been about innovation and pushing the boundaries, and the 2.5.0 update is no…

Read more →

Golden Helix Receives New NIH SBIR Grant  

Sep 26, 2023

Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options  BOZEMAN, Mont. – Sep. 26, 2023 – Golden Helix, Inc. announced that it was awarded the NIH SBIR Grant 1R43HG013456-01 “Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options.”  Personalized medicine leveraging pharmacogenomics is gaining momentum to optimize drug choice, dosage, efficacy, and safety for…

Read more →

Golden Helix is Celebrating 25 Years of Excellence

Sep 19, 2023

Golden Helix Inc. celebrates 25 years as a leader in the genomics landscape. Built on solid Montanan values of work ethic and reliability, our journey began with Dr. Christophe Lambert’s vision in 1998. Our early triumphs in Genome-Wide Association Studies set the stage, but 2013 brought a transformative shift. Under…

Read more →

Advancing Precision Medicine: A Spotlight on Golden Helix’s VarSeq in Genomic Research and Clinical Applications

Aug 1, 2023

The field of genomic research and precision medicine is rapidly evolving, bringing forth innovative diagnostic and treatment approaches. The cutting-edge techniques and technologies discussed in the following papers provide insight into how whole-exome sequencing (WES), whole-genome sequencing (WGS), and deep computational analysis are reshaping healthcare. Our spotlight is on recent…

Read more →

Embracing the Future: Transitioning from Marketing Coordinator to Senior Marketing Manager at Golden Helix

Apr 10, 2023

Hello everyone! I’m Casey Fullem, and I am delighted to announce my recent promotion from Marketing Coordinator to Senior Marketing Manager at Golden Helix. Having had the privilege of contributing to the company’s growth over the past 1.5 years, I am eager to continue driving our success through the application…

Read more →

ACMG 2023 Insights: Exploring Whole Exome Sequencing, Hereditary Cancer, and Prenatal Genetics

Mar 28, 2023

Our team at Golden Helix remains committed to advancing genomics and personalized medicine. We actively participate in industry conferences to stay current with the latest developments, such as the recent ACMG 2023 in Salt Lake City, Utah. This event facilitated valuable insights and discussions on several topics. Three key areas…

Read more →

Golden Helix named as a Best Global Bioinformatics Firm of 2023 by the Corporate Excellence Awards

Jan 19, 2023

We are thrilled to announce that our company has been named the Best Global Bioinformatics Firm of 2023 by the Corporate Excellence Awards. This recognition is a testament to the hard work and dedication of our team, who are committed to delivering the highest quality bioinformatics solutions to our customers.…

Read more →